No abstract available
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Biomarkers / metabolism
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / metabolism
-
Female
-
Glucagon-Like Peptide 1 / analogs & derivatives*
-
Glucagon-Like Peptide 1 / therapeutic use
-
Humans
-
Hypoglycemic Agents / therapeutic use*
-
Liraglutide
-
Male
-
Middle Aged
-
Risk Assessment
-
Young Adult
Substances
-
Biomarkers
-
Hypoglycemic Agents
-
Liraglutide
-
Glucagon-Like Peptide 1